LASHARYL BARTON-COLLUM: Open Payments
NPI 1245868249 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,646 in 242 payments from 18 companies in 2025. Trend: 2023 $3,674 · 2024 $3,109 · 2025 $3,646
Food & beverage: $3,643Education: $3
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $650 |
| Otsuka America Pharmaceutical, Inc. | 58 | $571 |
| Alkermes, Inc. | 21 | $476 |
| Lundbeck LLC | 23 | $404 |
| ABBVIE INC. | 29 | $381 |
| Janssen Pharmaceuticals, Inc | 21 | $292 |
| E.R. Squibb & Sons, L.L.C. | 22 | $252 |
| Neurocrine BioSciences, Inc. | 10 | $180 |
| Vanda Pharmaceuticals Inc. | 5 | $108 |
| Corium, LLC | 3 | $68 |
Products named: REXULTI, UZEDY, VRAYLAR, LYBALVI, COBENFY, INVEGA SUSTENNA, INGREZZA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
